USPTO serial 75321297
Serial No. 75321297
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOOD, CAROLINE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 75321297?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
BERNARD R GANS
BERNARD R GANS JEFFER MANGELS BUTLER & MARMARO LLP2121 AVE OF THE STARS 10TH FLLOS ANGELES, CA 90067UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceuticals and pharmaceutical preparations based on natural medicines that; reduce the symptoms of premenstrual stress (PMS), regulate the menstrual cycle, increase the production of milk in a woman who is breast feeding, and alter the amounts of the hormone that causes the production of breast milk; cause significant diarrhea, improve wound healing, reduce inflammation, reduce itching, protect the liver and are used in the treatment of arthritis; reduce diarrhea and inflammation; reduce the discomfort of painful menstrual periods, reduce muscle and joint pain and throat soreness, cause sleepiness and are therapy for bronchitis; reduce cramping pain, digestive tract distress and inflammation of the skin; improve hemorrhoids, swelling due to some causes of insufficient blood flow in veins (venous insufficiency), and varicose veins; increase resistance to infections caused by bacteria, improve the healing of superficial skin wounds, and assist the treatment of recurring infections of the respiratory and urinary tracts; promote the flow in menstruation and reduce cramping pain; reduce certain types of skin outbreaks (eczema), reduce the pain of migraine headaches and menstrual periods, and are used in the treatment of asthma and arthritis; reduce certain fatty substances in the blood, including triglycerides and cholesterol; reduce the stickiness of platelets and clotting; and increase the breakdown of blood clots; reduce nausea by acting on the digestive tract; are used in the treatment of inadequate blood flow in vessels in the extremities, including cramping pain in the calf caused by walking, and in the brain; of ringing of the ears; and of abnormal changes in the light sensing portion of the eye, i.e., retina; reduce stress and damage caused to the liver; increase sexual appetite; are used in the treatment of cancer; and are a general tonic; reduce cholesterol levels in the blood and increase the length of one's life; improve heart function, heart conditions associated with the elderly, mild heart pain brought on by exertion (angina), and mild irregularities of the heart beat; and lower blood pressure; are used in the treatment of degenerative arthritis; reduce distress of the intestinal tract; cause sleepiness and treats insomnia; are used in the treatment of ulcers; reduce inflammation; protect the liver, including against scarring (cirrhosis) and inflammation (hepatitis); are a free radical scavenger and antioxidant; reduce pain and inflammation and improve insomnia and bronchial asthma; improve urination, are used in the treatment of non-cancerous enlargement of the male prostate gland, and help rid the body of worms; improve disorders of the male prostate gland, including non-cancerous enlargement; promote the flow in menstruation; are used in the treatment of cancer and diabetes; and in some ways act like an antioxidant; reduce the symptoms caused by non-cancerous enlargement of the male prostate gland; lower blood pressure; stimulate the body's immune system; and reduce stress from environmental factors; improve mild to moderate mood depression; help in AIDS; increase resistance to infections caused by bacteria and viruses; help protect a developing fetus against damage from exposure to drugs, chemicals and certain other materials; stimulate the body's immune system; help the body remove excess fluid through urination; improve rheumatism; and stimulate the growth of hair; promote calm; modify the activity of the body's immune system; improve the clearing of mucous from the lung; treat immunodeficiencies | ACTIVE | — |
| 040 | pharmaceutical manufacturing to the order and specifications of others | ACTIVE | — |
| 042 | pharmaceutical research; medical research in the nature of identifying and quantifying the active and effective components of natural medicines so that pharmaceutical versions can be made and tested | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 2, 2002 | PAPER RECEIVED | — | |
| Oct 19, 2000 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 19, 2000 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 15, 2000 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 15, 2000 | REIN | REINSTATED | — |
| Nov 8, 1999 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 11, 1999 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 16, 1999 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 15, 1999 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 4, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 1998 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 9, 1998 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Oct 2, 1998 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Oct 2, 1998 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 18, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 24, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 17, 1998 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Apr 20, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 1998 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 1998 | DOCK | ASSIGNED TO EXAMINER | — |